Solar Industries India stock
SOLARINDS.NSNSESolar Industries India Limited, Basic MaterialsISIN INE343H01029
74Score 74 out of 100, Strong
Price and trend
66 / 100
Price history
+37% in one yearThe chart shows daily closes over 18 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 12% above it.
Since April 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 60).
The price is 14% below its 52-week high. Largest decline in 18 years: 34% (January 2020 to April 2020).
Chart figures for advanced users
- SMA 50$211.09
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$183.36
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)60
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$125.64
- The lowest closing price of the last twelve months.
- Resistance$239.66
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Solar Industries India Limited belongs to the Chemicals (Specialty) industry (India) and, with a market value of $18.62B, is number 17 of 108 companies in its industry on MEQIRI.
- In fiscal 2026 it reported revenue of $1.05B (up 30.5% year on year) and earnings of $179.04M (up 38.7%).
- For fiscal 2027, analysts expect on average revenue of $1.52B (up 44.9%) and adjusted earnings per share of $3.05 (up 54%).
Show more
- MEQIRI Score 74 out of 100 (Strong): rank 47 of 467 in Basic Materials, median 58.
- The P/E is 77.1 (Chemicals (Specialty) median 20.2, own median of recent years 44.6).
- Our model puts fair value at $87.84, with the price 130% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Earnings per share growingUp 43.4% a year since 2021.Growth 76
- Growing faster than its industryRevenue up 31.4% a year since 2021, Chemicals (Specialty) median 12.7%.Growth 76
- High return on capitalReturn on invested capital 29.1% in fiscal 2026, Chemicals (Specialty) median 5.8%.Profitability 88
Weaknesses
- Richly valuedP/E 77.1, Chemicals (Specialty) median 20.2, own median 44.6.Valuation 15
- Above fair valuePrice 130% above the fair value of $87.84.Valuation 15
- Negative free cash flowFree cash flow −$132.87M over the last 12 months.
Its standout strengths are profitability and stability, while valuation holds the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamentals are strong, with stable profits.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk not measured
How well MEQIRI warnsFor stocks from Japan, China, Hong Kong, Taiwan, Korea, Canada, India and Brazil we only show crash risk once a separate backtest shows that it warns as well there as in the US and Europe.
Valuation
Valuation signal
Significantly overvaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $62.75 and expensive above $146.41 (uncertainty high, one part of the fair value is more than twice the other).
The two parts of the fair value come to $121.89 (cash-flow model) and $53.79 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.
Calculated with a cost of equity of 12.8%. At 13.8% the fair value would be $77.43, at 11.8% it would be $102.66.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (20.2).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 52.7% on the twelve months before. Revenue has grown strongly since 2007, at around 23% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2026: gross 39%, operating 24%, net 17%.
Debt & balance sheet
latest quarterThe balance sheet is solid, with low debt and comfortable interest coverage.
Earnings
- Next earnings
- 14 Feb 2027in 94 days
- Last reported
- 3 Nov 2026EPS reported $0.73 (expected $0.61)above expectations
Analyst estimates
Earnings estimates have barely changed since 23 Oct 2026.
- Earnings per share
- $3.05+0.3%
- Revenue
- $1.52B+0.4%
- Earnings per share
- $3.810.0%
- Revenue
- $2.14B+0.2%
MEQIRI has stored the estimates since 23 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Solar Industries India
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 74
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Ems-Chemie HoldingEMSN.SW $23.84B74
- International Flavors & FragrancesIFF $20.69B48
- Nippon Paint Holdings4612.T $20.5B75
- LyondellBasell IndustriesLYB $20.23B62
- Pidilite IndustriesPIDILITIND.NS $17.12B79
- Nippon Sanso Holdings4091.T $16.34B71
- Sociedad Química y Minera de ChileSQM $15.64B71
- SymriseSY1.DE $14.57B60
ETFs that hold Solar Industries India
Held by 11 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares MSCI India UCITS ETFQDV5 | 0.31% | 0.65% | €4.91B |
| iShares MSCI EM Asia UCITS ETFCEBL | 0.05% | 0.20% | €6.97B |
| Vanguard FTSE Emerging Markets UCITS ETF (USD) AccumulatingVFEA | 0.05% | 0.17% | €5.24B |
Show 4 more
| iShares MSCI EM UCITS ETF USD (Dist)IQQE | 0.04% | 0.18% | €8.33B |
| iShares Core MSCI EM IMI UCITS ETFIS3N | 0.04% | 0.18% | €37.17B |
| Vanguard FTSE All-World UCITS ETF (USD) AccumulatingVWCE | 0.00% | 0.14% | €79.59B |
| Vanguard FTSE Global All-Cap UCITS ETF Accum USDVGLA | 0.00% | 0.07% | €3.9B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = ₹93.6946)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 10 Apr 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.